Prelude Therapeutics Inc

PRLD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001678660

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Apr 23, 20266:48 PM ETApr 21, 2026ORBIMED ADVISORS LLC and 3 othersDirector, 10% OwnerPPurchaseCommon Stock+2.82M$4.44+$12.5M1.13MNew positionSEC
Apr 23, 2026Apr 21, 2026Bonita David PDirector, 10% OwnerPPurchaseCommon Stock+2.82M$4.44+$12.5M1.13MNew positionSEC
Apr 22, 20264:15 PM ETApr 21, 2026BAKER JULIAN and 5 othersDirector, 10% OwnerPPurchaseCommon Stock · Derivative+2.25M$4.4399+$10M20.11M–SEC
Mar 27, 2025Mar 25, 2025Combs AndrewChief Chemistry OfficerPPurchaseCommon Stock+100K$0.69+$69K480.12K+26.3%SEC
Mar 27, 2025Mar 25, 2025Vaddi KrishnaCEOPPurchaseCommon Stock+675K$0.69+$465.75K2M+51.0%SEC
Mar 24, 2025Mar 20 – Mar 21, 2025Vaddi KrishnaCEOPPurchaseCommon Stock+20.42K$0.73+$14.9K1.32M+1.6%SEC
Mar 18, 2025Mar 14 – Mar 17, 2025Vaddi KrishnaCEOPPurchaseCommon Stock+39.11K$0.75+$29.33K1.3M+3.1%SEC
Mar 14, 2025Mar 12 – Mar 13, 2025Vaddi KrishnaCEOPPurchaseCommon Stock+97.5K$0.7151+$69.73K1.26M+8.4%SEC
Jan 3, 2025Dec 31, 2024Vaddi KrishnaCEOPPurchaseCommon Stock+5K$1.21+$6.05K142.55K+3.6%SEC
Jan 2, 2025Dec 30, 2024Vaddi KrishnaCEOPPurchaseCommon Stock+10K$1.20+$12K137.55K+7.8%SEC
Dec 26, 2024Dec 20 – Dec 23, 2024Combs AndrewChief Chemistry OfficerPPurchaseCommon Stock+63.08K$1.3593+$85.74K377.62K+20.1%SEC
Dec 20, 2024Dec 19, 2024Lim Bryant DavidCLO, Interim CFO, Corp Sec.PPurchaseCommon Stock+25K$0.91+$22.75K27.4K+1,041.7%SEC
Dec 20, 2024Dec 18, 2024Vaddi KrishnaCEOPPurchaseCommon Stock+100K$0.93+$93K1.17M+9.4%SEC
Dec 20, 2024Dec 19, 2024Vaddi KrishnaCEOPPurchaseCommon Stock+6.89K$0.89+$6.13K127.55K+5.7%SEC
May 26, 2023May 24 – May 25, 2023Vaddi KrishnaCEOPPurchaseCommon Stock+1.9K$5.1521+$9.79K1.07M+0.2%SEC
May 25, 2023May 24, 2023Lim Bryant DavidChief Legal Officer, Corp Sec.PPurchaseCommon Stock+2.4K$5.39+$12.94K2.4KNew positionSEC
May 25, 2023May 23, 2023Chardonnet LaurentChief Financial OfficerPPurchaseCommon Stock+5K$5.50+$27.5K42.17K+13.5%SEC
May 25, 2023May 23, 2023Vaddi KrishnaCEOPPurchaseCommon Stock+11.86K$5.63+$66.75K1.07M+1.1%SEC
May 24, 20235:09 PM ETMay 22, 2023ORBIMED ADVISORS LLC and 2 othersDirector, 10% OwnerPPurchaseCommon Stock+869.57K$5.75+$5M10.12M+9.4%SEC
May 24, 2023May 22, 2023Bonita David PDirector, 10% OwnerPPurchaseCommon Stock+869.57K$5.75+$5M10.12M+9.4%SEC
Apr 6, 2023Apr 6, 2023Huang JanePresident, CMOSSaleCommon Stock−13.28K$6.12−$81.27K24.22K−35.4%SEC
Dec 21, 2022Dec 20, 2022Vaddi KrishnaCEOPPurchaseCommon Stock+19.19K$5.13+$98.43K120.67K+18.9%SEC
Dec 12, 2022Dec 8, 2022Chardonnet LaurentChief Financial OfficerPPurchaseCommon Stock+10K$4.76+$47.6K35.87K+38.7%SEC
Jun 1, 2022Jun 1, 2022Chardonnet LaurentChief Financial OfficerPPurchaseCommon Stock+10K$4.23+$42.3K24.5K+69.0%SEC
Dec 17, 2021Dec 15, 2021Morosini DeborahEVP, Chief of Clinical AffairsSSaleCommon Stock−28.75K$13.00−$373.76K444−98.5%SEC
Dec 15, 2021Dec 13 – Dec 14, 2021Combs AndrewEVP, Head of ChemistryPPurchaseCommon Stock+8K$11.86+$94.88K268.38K+3.1%SEC
Nov 18, 2021Nov 16, 2021Morosini DeborahEVP, Chief of Clinical AffairsSSaleCommon Stock−28.75K$15.8778−$456.5K444−98.5%SEC
Oct 6, 2021Oct 5, 2021Mauro David JChief Medical OfficerSSaleCommon Stock−15K$30.9557−$464.34K0−100.0%SEC
Sep 9, 2021Sep 7, 2021Mauro David JChief Medical OfficerSSaleCommon Stock−15K$36.685−$550.27K0−100.0%SEC
Sep 7, 2021Sep 2, 2021Pierce ChristopherEVP and Chief of Business OperSSaleCommon Stock−17K$41.6776−$708.52K3.75K−81.9%SEC
Aug 30, 2021Aug 26 – Aug 27, 2021Scherle PeggyChief Scientific OfficerSSaleCommon Stock−7.71K$35.7492−$275.77K172.92K−4.3%SEC
Aug 27, 2021Aug 25, 2021Piper BrianChief Financial OfficerSSaleCommon Stock−8.33K$33.3403−$277.82K0−100.0%SEC
Aug 17, 2021Aug 13, 2021Scherle PeggyChief Scientific OfficerSSaleCommon Stock−2.29K$35.07−$80.17K172.92K−1.3%SEC
Aug 9, 2021Aug 5, 2021Mauro David JChief Medical OfficerSSaleCommon Stock−15K$31.094−$466.41K0−100.0%SEC
Jul 29, 2021Jul 27, 2021Scherle PeggyChief Scientific OfficerSSaleCommon Stock−20K$35.4718−$709.44K172.92K−10.4%SEC
Jul 8, 2021Jul 6, 2021Mauro David JChief Medical OfficerSSaleCommon Stock−15K$27.4757−$412.14K0−100.0%SEC